Skip to main content
ARWR logo

Arrowhead Pharmaceuticals, Inc.

ARWRNASDAQHealthcareBiotechnology

$58.98Today:- (-)1Y +56.25%

As of Oct 26, 2026 close

Market cap
$8.46B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$36.73$95.49
Volume (live)
-
Avg. volume (3M)
2.22M

Arrowhead Pharmaceuticals, Inc. (ARWR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Arrowhead Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(23 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$109.00
+84.81% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ARWR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
UBS
BuyInitiates
$109.00
Edward Tenthoff
Piper Sandler
BuyReiterates
$126.00
Brian Cheng
JP Morgan
BuyReiterates
-
Eric Joseph
Citi
BuyMaintains
$108.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$120.00
Unknown Analyst
UBS
BuyInitiates
$63.00 → $109.00
Eric Joseph
Citi
BuyMaintains
$108.00
Jason Gerberry
BofA Securities
BuyMaintains
$100.00
Andrea Newkirk
Goldman Sachs
HoldInitiates
$74.00
Patrick Trucchio
HC Wainwright
BuyMaintains
$120.00
Brian Cheng
JP Morgan
BuyReiterates
-
Eric Joseph
Citi
BuyReiterates
-
Michael Ulz
Morgan Stanley
BuyReiterates
$120.00
James Condulis
Stifel Nicolaus
BuyMaintains
$104.00
Joseph Thome
TD Cowen
BuyMaintains
-
Luca Issi
RBC Capital
BuyMaintains
$100.00
Michael Ulz
Morgan Stanley
BuyReiterates
$120.00
Joseph Thome
TD Cowen
BuyMaintains
-
Luca Issi
RBC Capital
BuyMaintains
$100.00
Edward Tenthoff
Piper Sandler
BuyReiterates
$126.00
Madison Elsaadi
B Riley
BuyReiterates
$123.00
Keay Nakae
Chardan Capital
BuyMaintains
$115.00
Jason Gerberry
BofA Securities
BuyReiterates
$100.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ARWR?

The analyst consensus rating for ARWR is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for ARWR?

The average 12-month price target for ARWR is $109.00, representing an upside of 84.8% from the Oct 26, 2026 close of $58.98.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.